Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 16;9:780461. doi: 10.3389/fcell.2021.780461

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Lin, Wang, Wang, Shao, Yang, Cao, Feng, Gao and He.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Predictive potential of SRS in immunotherapeutic benefits. (A). The distribution of TIDE scores between patients with a higher SRS score and those with a lower SRS score in four different cohorts as indicated. (B). The distribution of IPS in the high-risk and low-risk groups in the TCGA dataset. (C). Kaplan-Meier curves for high and low SRS score patient groups in the IMvigor210 cohort. (D). Kaplan-Meier curves for four patient groups stratified by SRS and PD-L1 expression. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively.